SCHEMBL6404486

SCHEMBL6404486

COc1ccccc1C(c1cccc2ccccc12)[C@@H](C#N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 3/20 0.39
LMNA P02545 1/20 0.39
FABP7 O15540 1/20 0.39
FABP3 P05413 1/20 0.39
FABP5 Q01469 1/20 0.39
SLC6A4 P31645 1/20 0.38
POLB P06746 2/20 0.38
HTT P42858 2/20 0.38
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
PTGS1 P23219 2/20 0.38
PTGS2 P35354 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659897 1.00 KMT2A (0.46) KMT2AMEN1L3MBTL1ALDH1A1KDM4E
SCHEMBL4659895 1.00 KMT2A (0.46) KMT2AMEN1L3MBTL1ALDH1A1KDM4E
SCHEMBL4660099 0.94 KMT2A (0.47) KMT2AMEN1L3MBTL1ALDH1A1KDM4E
SCHEMBL4661666 0.90 KMT2A (0.45) KMT2AMEN1ALDH1A1KDM4EHSD17B10
SCHEMBL4663676 0.89 ALDH1A1 (0.43) ALDH1A1LMNAHTTHPGDTDP1
SCHEMBL4661393 0.89 KMT2A (0.47) KMT2AMEN1L3MBTL1ALDH1A1KDM4E
SCHEMBL4661547 0.88 ALDH1A1 (0.46) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL4661400 0.85 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1KDM4EHSD17B10
SCHEMBL4659958 0.85 L3MBTL1 (0.43) KMT2AMEN1L3MBTL1ALDH1A1SLC6A4
SCHEMBL4661539 0.84 MEN1 (0.42) KMT2AMEN1L3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 KMT2A 2809/4885MEN1 2575/4885L3MBTL1 4004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.